取消接触隔离对医院相关产ESBL大肠埃希菌的影响:中断时间序列分析
Impact of Discontinuation of Contact Precautions on Healthcare-associated Extended Spectrum β-Lactamase-Producing Escherichia coli in a Large Tertiary Care Hospital: An Interrupted Time-series Analysis.
PubMed 文献 · Clin Infect Dis · 2026-01-01
在日内瓦大学医院,2019年取消了针对产ESBL大肠埃希菌的接触隔离。
要点
- 取消产ESBL大肠埃希菌接触隔离后,医院相关发病率无显著上升。
- 仅分析临床分离株时,结果与总体一致。
核心结论
- 在日内瓦大学医院,取消产ESBL大肠埃希菌的接触隔离后,医院相关发病率未见显著增加。
研究设计与样本
- 中断时间序列分析,纳入2016至2024年2336例医院相关产ESBL大肠埃希菌病例。
主要发现
- 基线发病率为每1万患者日3.1例。
- 仅限临床分离株分析时结果一致。
临床怎么用
- 对于产ESBL大肠埃希菌,可考虑取消常规接触隔离,但需结合本地流行病学监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
At Geneva University Hospitals, contact precautions for ESBL-producing Escherichia coli were discontinued in 2019. Among 2336 hospital-associated cases from 2016 to 2024, incidence was 3.1 per 10 000 patient days at baseline and showed no significant increase after discontinuation (slope change -0.04, P = .14). Results were consistent when limited to clinical isolates.
来源:Clin Infect Dis,查看原文。版权归原作者所有。
引用
- Musumeci S, Grant R, Sobel J, et al. Impact of Discontinuation of Contact Precautions on Healthcare-associated Extended Spectrum β-Lactamase-Producing Escherichia coli in a Large Tertiary Care Hospital: An Interrupted Time-series Analysis. Clin Infect Dis. 2026. PMID: 41153075. doi:10.1093/cid/ciaf594
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。